Brycen Gray and Ben Price COVID–19 Neurological Impact Act
United States117th CongressHR-5772House of Representatives
Updated: Oct 29, 2021
Summary
Brycen Gray and Ben Price COVID-19 Neurological Impact Act This bill authorizes grants and requires other activities to address neurological and psychiatric illnesses associated with COVID-19 infection. Specifically, the National Science Foundation may award competitive grants for multidisciplinary research on such illnesses. In addition, the White House Office of Science and Technology Policy must establish a temporary interagency working group to coordinate relevant federal programs, data collection, and other activities focused on neurological and psychiatric illnesses associated with COVID-19 infection. The working group must also engage with researchers and nonfederal stakeholders to ensure the sharing and dissemination of relevant research, information, and best practices pertaining to those illnesses. The working group terminates after five years.
Bill texts
All available records shown.
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Science, Space, and Technology, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
House of Representatives
Referred to the Subcommittee on Research and Technology.
House of Representatives
Referred to the Subcommittee on Health.
House of Representatives
All available records shown.